|
1.
|
Wong S and Witte ON: The BCR-ABL story:
Bench to bedside and back. Annu Rev Immunol. 22:247–306. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Demiroglu A, Steer EJ, Heath C, Taylor K,
Bentley M, Allen SL, Koduru P, Brody JP, Hawson G, Rodwell R, et
al: The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1:
Transforming activity and specific inhibition of FGFR1 fusion
proteins. Blood. 98:3778–3783. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Pini M, Gottardi E, Scaravaglio P,
Giugliano E, Libener R, Baraldi A, Muzio A, Cornaglia E, Saglio G
and Levis A: A fourth case of BCR-FGFR1 positive CML-like disease
with t(8;22) translocation showing an extensive deletion on the
derivative chromosome 8p. Hematol J. 3:315–316. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Murati A, Arnoulet C, Lafage-Pochitaloff
M, Adélaide J, Derré M, Slama B, Delaval B, Popovici C, Vey N,
Xerri L, et al: Dual lympho-myeloproliferative disorder in a
patient with t(8;22) with BCR-FGFR1 gene fusion. Int J Oncol.
26:1485–1492. 2005.PubMed/NCBI
|
|
5.
|
Fioretos T, Panagopoulos I, Lassen C,
Swedin A, Billström R, Isaksson M, Strömbeck B, Olofsson T,
Mitelman F and Johansson B: Fusion of the BCR and the fibroblast
growth factor receptor-1 (FGFR1) genes as a result of
t(8;22)(p11;q11) in a myeloproliferative disorder: The first fusion
gene involving BCR but not ABL. Genes Chromosomes Cancer.
32:302–310. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Agerstam H, Lilljebjörn H, Lassen C,
Swedin A, Richter J, Vandenberghe P, Johansson B and Fioretos T:
Fusion gene-mediated truncation of RUNX1 as a potential mechanism
underlying disease progression in the 8p11 myeloproliferative
syndrome. Genes Chromosomes Cancer. 46:635–643. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Richebourg S, Theisen O, Plantier I, Parry
A, Soenen-Cornu V, Lepelley P, Preudhomme C, Renneville A, Laï JL
and Roche-Lestienne C: Chronic myeloproliferative disorder with
t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic
chronic myelogeneous leukemia. Genes Chromosomes Cancer.
47:915–918. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Patnaik MM, Gangat N, Knudson RA, Keefe
JG, Hanson CA, Pardanani A, Ketterling RP and Tefferi A: Chromosome
8p11.2 translocations: Prevalence, FISH analysis for FGFR1 and
MYST3 and clinicopathologic correlates in a consecutive cohort of
13 cases from a single institution. Am J Hematol. 85:238–242. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Dolan M, Cioc A, Cross NC, Neglia JP and
Tolar J: Favorable outcome of allogeneic hematopoietic cell
transplantation for 8p11 myeloproliferative syndrome associated
with BCR-FGFR1 gene fusion. Pediatr Blood Cancer. 59:194–196. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Baldazzi C, Iacobucci I, Luatti S,
Ottaviani E, Marzocchi G, Paolini S, Stacchini M, Papayannidis C,
Gamberini C, Martinelli G, et al: B-cell acute lymphoblastic
leukemia as evolution of a 8p11 myeloproliferative syndrome with
t(8;22)(p11;q11) and BCRFGFR1 fusion gene. Leuk Res. 34:e282–e285.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Wakim JJ, Tirado CA, Chen W and Collins R:
t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B acute
lymphoblastic leukemia: Report of a case treated with sorafenib and
review of the literature. Leuk Res. 35:e151–e153. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Haslam K, Langabeer SE, Kelly J, Coen N,
O'Connell NM and Conneally E: Allogeneic hematopoietic stem cell
transplantation for a BCR-FGFR1 myeloproliferative neoplasm
presenting as acute lymphoblastic leukemia. Case Rep Hematol.
2012:6209672012.PubMed/NCBI
|
|
13.
|
Lee SG, Park TS, Lee ST, Lee KA, Song J,
Kim J, Suh B, Choi JR and Park R: Rare translocations involving
chromosome band 8p11 in myeloid neoplasms. Cancer Genet Cytogenet.
186:127–129. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Kim SY, Oh B, She CJ, Kim HK, Jeon YK,
Shin MG, Yoon SS and Lee DS: 8p11 myeloproliferative syndrome with
BCR-FGFR1 rearrangement resenting with T-lymphoblastic lymphoma and
bone marrow stromal cell proliferation: A case report and review of
the literature. Leuk Res. 35:e30–e34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Morishige S, Oku E, Takata Y, Kimura Y,
Arakawa F, Seki R, Imamura R, Osaki K, Hashiguchi M, Yakushiji K,
et al: A Case of 8p11 myeloproliferative syndrome with BCR-FGFR1
gene fusion presenting with trilineage acute leukemia/lymphoma,
successfully treated by cord blood transplantation. Acta Haematol.
129:83–89. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Shimanuki M, Sonoki T, Hosoi H, Watanuki
J, Murata S, Mushino T, Kuriyama K, Tamura S, Hatanaka K, Hanaoka N
and Nakakuma H: Acute leukemia showing t(8;22)(p11;q11),
myelodysplasia, CD13/CD33/CD19 expression and immunoglobulin heavy
chain gene rearrangement. Acta Haematol. 129:238–242. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Matikas A, Tzannou I, Oikonomopoulou D and
Bakiri M: A case of acute myelogenous leukaemia characterised by
the BCR-FGFR1 translocation. BMJ Case Rep.
2013:bcr20130088342013.PubMed/NCBI
|
|
18.
|
Roumiantsev S, Krause DS, Neumann CA,
Dimitri CA, Asiedu F, Cross NC and Van Etten RA: Distinct stem cell
myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and
BCR-FGFR1 fusion genes from 8p11 translocations. Cancer Cell.
5:287–298. 2004. View Article : Google Scholar : PubMed/NCBI
|
